Search

Viatris Inc

Suletud

SektorTervishoid

17.82 2.24

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.8

Max

17.96

Põhinäitajad

By Trading Economics

Sissetulek

-295M

-119M

Müük

240M

3.8B

Aktsiakasum

0.69

Dividenditootlus

2.83

Kasumimarginaal

-3.162

Töötajad

30,000

EBITDA

9.4M

653M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+9.05% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

2.83%

2.25%

Järgmine tulemuste avaldamine

5. nov 2026

Järgmine dividendimakse kuupäev

14. dets 2026

Järgmine aktsia dividendi kuupäev (ex-date)

23. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-890M

20B

Eelmine avamishind

15.58

Eelmine sulgemishind

17.82

Uudiste sentiment

By Acuity

100%

0%

300 / 339 Pingereas Healthcare

Viatris Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. sept 2026, 22:45 UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

24. sept 2026, 20:02 UTC

Viatris Inc is trading higher, reaching a peak cumulative return and positioned above its 20-day moving average during Thursday's session.

23. sept 2026, 20:07 UTC

News

Shares of Viatris Inc declined despite Oppenheimer initiating coverage with an Outperform rating and a $25 price target, amid broader market downward pressure.

22. sept 2026, 22:30 UTC

Viatris Inc is declining in after-market trading, moving lower since Tuesday's close despite peaking above the previous close earlier in the session.

21. sept 2026, 23:01 UTC

Viatris Inc is trading modestly higher in after-market hours, reaching a peak return since Monday's close and staying near the upper end of its one-month range.

18. sept 2026, 21:01 UTC

Viatris Inc. is trading modestly higher in after-market hours, currently positioned above its 20-day moving average and near the upper end of its one-month range.

17. sept 2026, 20:08 UTC

Viatris Inc. shares are up modestly, reaching a peak above the previous close while remaining above the 20-day moving average.

16. sept 2026, 23:16 UTC

Viatris Inc. is trading modestly lower in after-market hours, having experienced unusual volatility after initially rising earlier in the session.

15. sept 2026, 20:07 UTC

Viatris shares are roughly flat as the broader market declines amid a significant drop in the NY Empire State Manufacturing Index and rising oil prices.

14. sept 2026, 20:07 UTC

Viatris Inc's shares are higher today, continuing a gradual increase since Friday's close despite an earlier pullback. No specific news was identified.

11. sept 2026, 21:41 UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

10. sept 2026, 20:07 UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

9. sept 2026, 19:36 UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

8. sept 2026, 19:46 UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

4. sept 2026, 22:14 UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

3. sept 2026, 19:56 UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2. sept 2026, 19:46 UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

1. sept 2026, 20:09 UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

31. aug 2026, 23:14 UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

28. aug 2026, 19:51 UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

27. aug 2026, 23:02 UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

26. aug 2026, 23:01 UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

25. aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

24. aug 2026, 19:56 UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

21. aug 2026, 23:01 UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

20. aug 2026, 20:06 UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

19. aug 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

18. aug 2026, 23:01 UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

17. aug 2026, 23:16 UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

14. aug 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

Võrdlus sarnastega

Hinnamuutus

Viatris Inc Prognoos

Hinnasiht

By TipRanks

9.05% tõus

12 kuu keskmine prognoos

Keskmine 19.444 USD  9.05%

Kõrge 25 USD

Madal 13 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Viatris Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

5

Osta

3

Hoia

1

Müü

Sentiment

By Acuity

300 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.